Tyra Biosciences, Inc
Tyra Biosciences is a clinical-stage biotechnology company developing oral FGFR inhibitors for oncology and genetically defined conditions.
SCHEDULE 13GSep 21Latest SEC filing
Sep 14Latest story
Sign inSign inTyra Biosciences is a clinical-stage biotechnology company developing oral FGFR inhibitors for oncology and genetically defined conditions.